fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

CARMAT publishes its second Shareholder Newsletter

Download

Further elements added to the ANSM file

Download

CARMAT wins the Best technology category at the European Mediscience Awards

Download

FYR 2011: a sound cash position of €29.4m at 31.12.2011

Download

CARMAT publishes its first Shareholder Newsletter

Download

Favorable opinion from the Patient Protection Committee

Download

CARMAT will present pre-clinical data at the 25th Annual Meeting of the European Association for Cardio-Thoracic Surgery

Read the article
Top of page